(LH-indol-7-YL)-( (pyrimidin-2 - YL-amino) methanone derivatives and related compounds as IGF-RL inhibitors for treating cancer

Details for Australian Patent Application No. 2006233535 (hide)

Owner Merck Patent GmbH

Inventors Kordowicz, Maria; Blaukat, Andree; Heinrich, Timo

Agent Davies Collison Cave

Pub. Number AU-B-2006233535

PCT Pub. Number WO2006/108487

Priority 10 2005 016 634.2 12.04.05 DE

Filing date 17 March 2006

Wipo publication date 19 October 2006

Acceptance publication date 2 February 2012

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/108487 Priority application(s): WO2006/108487

2 February 2012 Application Accepted

  Published as AU-B-2006233535

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006233537-Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents

2006233530-Purine derivatives as receptor-tyrosine kinase activityinhibitors